Skip to main content

NEW YORK (TheStreet) -- Shares of Amedisys Inc.  (AMED) - Get Amedisys, Inc. Report are spiking 29% to $20.73 today following the health care company's higher than expected second quarter earnings, helped by the closing some of its hospices and home health care centers to reduce costs.

Adjusted net income for the second quarter rose to $8 million, or 25 cents per share, up from $5.8 million, or 18 cents per share, a year earlier and beating the consensus estimate of 4 cents by 21 cents. 

Revenue fell -3.5% year-over-year to $305 million, compared to the $316 million in the same quarter of 2013, but ahead of analysts' estimate of $289.9 million.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Recommends

Amedisys announced yesterday that it entered into a new $70 million six year second lien term loan facility, with proceeds being used to pay down outstanding balances.

AMED data by YCharts

Image placeholder title

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.